ArticleSeminars in ophthalmology2024

Neoadjuvant Chemotherapy Alone or Combined with EGFR-Directed Targeted Therapy or Anti-PD-1 Immunotherapy for Locally Advanced Lacrimal Sac and Nasolacrimal Duct Carcinomas.

Jeremy Goldfarb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.